• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconBiotech

Biotech

Page 4 of 19
U.S. lawmakers are trying to bar Chinese biotech companies over fears about America’s failure to compete with China in the industry
Politics
U.S. lawmakers are trying to bar Chinese biotech companies over fears about America’s failure to compete with China in the industry
By Didi Tang and The Associated PressFebruary 19, 2024
Exclusive: Bionaut Labs raises an extension round in preparation for micro-robot clinical trials
Newsletters
Exclusive: Bionaut Labs raises an extension round in preparation for micro-robot clinical trials
By Allie GarfinkleFebruary 6, 2024
AI is in the early stages of upending the drug discovery and development process, but there will still need to be a ‘lab in the loop’
Conferences
AI is in the early stages of upending the drug discovery and development process, but there will still need to be a ‘lab in the loop’
By Sage LazzaroDecember 14, 2023
Evofem, the startup trying to survive the broken birth-control market, finally sells itself
Features
Evofem, the startup trying to survive the broken birth-control market, finally sells itself
By Maria AspanDecember 13, 2023
Why a biotech firm’s market value jumped from $3 million to $130 million in a day and is still way up from its ‘almost unfathomably low valuation’
Health
Why a biotech firm’s market value jumped from $3 million to $130 million in a day and is still way up from its ‘almost unfathomably low valuation’
By Angel Adegbesan and BloombergOctober 13, 2023
Republican presidential candidate Vivek Ramaswamy standing behind a podium holding up peace signs.
Politics
How Vivek Ramaswamy, the surprise GOP debate star, made his fortune and triggered his critics
By Paolo ConfinoAugust 24, 2023
Noubar Afeyan, co-founder and chairman of Moderna and founder and chief executive officer of Flagship Pioneering.
Features
The Moderna COVID-19 vaccine was the ultimate home run for this biotech venture firm. It’s a tough act to follow
By Paolo ConfinoAugust 10, 2023
Portraits of Francis deSouza, Lina Khan, and Carl Icahn.
Leadership
Inside Illumina’s $8 billion deal that spurred a proxy fight with Carl Icahn and the ouster of 2 prominent Black Silicon Valley executives
By Lila MacLellanJuly 27, 2023
NYSE trader
Finance
The A.I. mania is so red hot that a small $50 million investment from Nvidia sent an obscure biotech firm’s shares up a record 78%
By Angel Adegbesan and BloombergJuly 12, 2023
Illumina CEO Francis deSouza resigns after proxy battle with Carl Icahn
Finance
Illumina CEO Francis deSouza resigns after proxy battle with Carl Icahn
By Tiago Ramos Alfaro and BloombergJune 11, 2023
Can an A.I. algorithm spot the next Facebook or Uber? The founder of this European VC firm thinks so
Newsletters
Can an A.I. algorithm spot the next Facebook or Uber? The founder of this European VC firm thinks so
By Lucy BrewsterMay 24, 2023
Pipette adding sample to petri dish with DNA profiles in background
Newsletters
A.I.-fueled biotech startups are having a moment—and one just raised $300 million in a Series A
By Lucy BrewsterMay 23, 2023
How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own
Health
How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own
By Arthur Allen and KFF Health NewsApril 13, 2023
The Silicon Valley Bank meltdown could be a disaster for downtrodden biotech startups
Tech
The Silicon Valley Bank meltdown could be a disaster for downtrodden biotech startups
By Angelica Peebles, Ilena Peng and BloombergMarch 10, 2023
The 11 most promising health tech startups, according to Silicon Valley VCs
Tech
The 11 most promising health tech startups, according to Silicon Valley VCs
By Lucy BrewsterOctober 24, 2022
1
  • 2
  • 3
  • 4
  • 5
  • 6
...19
Most Popular
Success
Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stockplaceholder alt text
By Sasha RogelbergJuly 20, 2026
Success
‘I want to die broke’: Billionaire philanthropist Denny Sanford dies after giving away $4 billionplaceholder alt text
By Sydney LakeJuly 20, 2026
AI
'Dr. Doom' Nouriel Roubini says we're headed for universal basic income or 'some form of socialism' as AI revolutionizes work—He calls that optimisticplaceholder alt text
By Jason MaJuly 18, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.